Yield10 Bioscience, Inc.
YTENQ
$0.015
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 400.00% | -100.00% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 400.00% | -100.00% | -- | -- |
| Cost of Revenue | -18.00% | -36.82% | 3.81% | 5.81% | -7.69% |
| Gross Profit | 42.18% | 49.29% | -8.83% | -11.76% | 2.72% |
| SG&A Expenses | 20.00% | -19.08% | -8.27% | -1.25% | 9.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.38% | -29.02% | -1.34% | 2.83% | 3.62% |
| Operating Income | 12.65% | 35.79% | -1.34% | -6.10% | -6.72% |
| Income Before Tax | 12.03% | 34.64% | -2.90% | -7.07% | -7.19% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 12.03% | 34.64% | 1.12% | -6.79% | -6.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.03% | 34.64% | 1.12% | -6.79% | -6.91% |
| EBIT | 12.65% | 35.79% | -1.34% | -6.10% | -6.72% |
| EBITDA | 12.48% | 36.37% | -1.15% | -6.14% | -6.65% |
| EPS Basic | 67.31% | 73.74% | 59.20% | 41.49% | 8.56% |
| Normalized Basic EPS | 67.31% | 73.74% | 57.54% | 41.34% | 8.32% |
| EPS Diluted | 67.31% | 73.73% | 59.20% | 41.49% | 8.56% |
| Normalized Diluted EPS | 67.31% | 73.74% | 57.54% | 41.34% | 8.32% |
| Average Basic Shares Outstanding | 169.12% | 148.92% | 142.33% | 82.50% | 16.90% |
| Average Diluted Shares Outstanding | 169.12% | 148.92% | 142.33% | 82.50% | 16.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
